The robotic assisted laparoscopic surgery market has seen considerable growth due to a variety of factors.
• In recent times, there has been a swift expansion in the market size of robotic-assisted laparoscopic surgery. The market is expected to surge from $140.9 billion in 2024 to $155.62 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.4%.
The previous growth can be linked to factors such as higher investments in healthcare robotics, a global increase in healthcare spending, a boost in training programs for robotic surgery, a rising demand for customized surgical solutions, and growth in research and development.
The robotic assisted laparoscopic surgery market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of robotic-assisted laparoscopic surgery is projected to expand significantly in the coming years, reaching $228.46 billion by 2029 with a compound annual growth rate (CAGR) of 10.1%.
Several factors have been identified as the catalysts for the growth during the forecast period - the rising demand for less intrusive surgical options, ramped-up adoption of mechanized tools, an increase in the incidence of degenerative bone diseases, a surge in chronic disease cases, and the escalating number of seniors. Notable market trends during this period will be technological innovation, incorporation of artificial intelligence (AI), machine learning application, simulation-based coaching, and advances in microrobotics.
An increase in the demand for surgical procedures is predicted to prompt an expansion in the robotic-assisted laparoscopic surgery market. Surgical operations, which involve changes to tissues and organs using either hands-on or instrumental methods, are in high demand due to a greater understanding of health and cosmetic possibilities, as well as an increase in chronic and age-specific conditions. Robotic-assisted laparoscopic surgery is a significant breakthrough in surgical operations, providing improved accuracy and management that render intricate procedures more manageable, while also reducing patient recuperation periods and surgical risks. For instance, the Aesthetic Society, a US-based plastic surgery and cosmetic medicine organization, reported in August 2023 that Americans spent over $11.8 billion on aesthetic procedures in 2022 alone, marking a 2% increase from the previous year. Hence, the growing demand for surgical operations is fuelling the expansion of the robotic-assisted laparoscopic surgery market.
The robotic-assisted laparoscopic surgerymarket covered in this report is segmented –
1) By Type: Robotic-Assisted Radical Prostatectomy, Robotic-Assisted Partial Nephrectomy, Robotic-Assisted Nephrectomy, Other Type
2) By Application: Hospitals, Ambulatory Surgical Center, Other Applications
3) By End-Use: Inpatient, Outpatient
Subsegments:
1) Robotic-Assisted Radical Prostatectomy: Robotic Prostatectomy Systems, Surgical Instruments For Prostatectomy, Training And Simulation Tools, Consumables And Accessories
2) Robotic-Assisted Partial Nephrectomy: Robotic Surgical Systems, Specialized Instruments For Partial Nephrectomy, Software Solutions For Planning And Simulation, Support And Maintenance Services
3) Robotic-Assisted Nephrectomy: Robotic Nephrectomy Platforms, Instrument Sets For Nephrectomy Procedures, Imaging And Navigation Tools, Training Programs For Surgeons
4) Other Types: Robotic-Assisted Cholecystectomy, Robotic-Assisted Hysterectomy, Robotic-Assisted Bariatric Surgery, Robotic-Assisted Colorectal Surgery
The key players in the industry of robotic-assisted laparoscopic surgery are honing their focus on innovating and incorporating advanced technologies like AI platforms for robotic surgery. The goal is to help surgeons perfect their methods, enhance their decision-making skills during surgery, and automate some tasks for better precision. They aim to augment surgical outcomes by supplying surgeons with real-time analysis, insight, and control tools. For example, in July 2024, Medtronic, a medical device firm based in the US, inaugurated the Live Stream feature for its Touch Surgery digital technology suite. This new feature allows secure live broadcasts of surgical procedures, thus establishing a virtual platform where medical experts can learn from observing skilled techniques from afar, replicating a first-hand experience. This technology heightens the post-operative analysis with 14 high-end AI algorithms that draw insights from the surgical footage, primarily for laparoscopic and robotic-assisted procedures. Such advancements align with the ongoing commitment to integrate superior computing abilities into operating rooms around the world with the aim to boost surgical training, increase operational efficiency, and enhance patient outcomes.
Major companies operating in the robotic-assisted laparoscopic surgery market are:
• Johnson & Johnson
• Medtronic PLC
• Doosan Corporation
• Intuitive Surgical Inc.
• Vicarious Surgical Inc.
• MedStar Health Inc.
• Meril Life Sciences Pvt. Ltd.
• MicroPort Scientific Corporation
• Corza Medical
• CMR Surgical Ltd.
• Distalmotion S.A.
• Titan Medical Inc.
• Medrobotics Corporation
• Asensus Surgical Inc.
• SS Innovations China Co. Ltd.
• Moon Surgical Inc.
• Levita Magnetics
• EndoQuest Robotics
• FreeHand Surgeon
• Shandong Weigao Surgical Robot
Asia-Pacific was the largest region in the robotic-assisted laparoscopic surgery market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the robotic-assisted laparoscopic surgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.